Morehead City, North Carolina Clinical Trials

A listing of Morehead City, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Efficacy Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor & licogliflozin combination therapy and each monotherapy, compared with placebo for treatment of adult patients with nonalcoholic steatohepatitis (NASH) and liver fibrosis

Novartis Investigative Site
 (204.6 away) Contact site
  • 27 views
  • 26 Jul, 2021
  • +95 other locations
Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

The purpose of AROAPOC3-2001 is to evaluate the efficacy and safety of ARO-APOC3 in participants with severe hypertriglyceridemia. Participants will receive 2 subcutaneous injections of ARO-APOC3.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +13 other locations
Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

The purpose of AROANG3-2001 is to evaluate the efficacy and safety of ARO-ANG3 in participants with mixed dyslipidemia. Participants will receive 2 subcutaneous injections of ARO-ANG3 or placebo.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +9 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

diabetes
body mass index
overweight or obesity
PMG Research of Wilmington, LLC
 (75.8 away) Contact site
  • 32 views
  • 01 Aug, 2021
  • +39 other locations
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

This is a blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with increased risk for cardiovascular (CV) disease.

testosterone topical
testosterone level
testosterone
replacement therapy
serum testosterone
Carteret Medical Group LLC /ID# 170771
 (1.1 away) Contact site
  • 16879 views
  • 30 Jul, 2021
  • +485 other locations
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

The purpose of this study is to see if the study drug, tirzepatide administered once weekly, is safe and effective as a treatment for Nonalcoholic Steatohepatitis (NASH).

Diabetes & Endocrinology Consultants, PC
 (1.1 away) Contact site
  • 212 views
  • 31 Jul, 2021
  • +172 other locations
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

The primary objective of this study is to compare belzutifan to everolimus with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) and to compare everolimus with respect to overall survival (OS). The hypothesis is …

tyrosine
everolimus
carcinoma
kinase inhibitor
vegf
University of North Carolina at Chapel Hill ( Site 1537)
 (0.1 away) Contact site
  • 168 views
  • 04 Aug, 2021
  • +181 other locations
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

The study includes 52 weeks, double-blind treatment period. Clinic visits will occur at Randomization and every four weeks from Week 4 through Week 52 and through End of Study period. The study includes a post-dosing study visit that will occur 4 weeks after the last dose of study drug. This …

fibrosis
diabetes
steatosis
type 2 diabetes mellitus
body mass index
Viking Clinical Site 153
 (1.1 away) Contact site
  • 151 views
  • 30 Jul, 2021
  • +91 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

flortaucipir
positron emission tomography
mini-mental state examination
florbetapir
alzheimer's disease
Sentara Neurology Specialists
 (148.7 away) Contact site
  • 80 views
  • 24 Jul, 2021
  • +389 other locations
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in …

fever
headache
covid-19
myalgia
cough
East Carolina University
 (70.2 away) Contact site
  • 2402 views
  • 02 Aug, 2021
  • +214 other locations